Quotes for Curasight A/S
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Ulrich Krasilnikoff
Chairperson of the Board
- Kirsten Drejer
Board
- Andreas Kjær
- Charlotte Vedel
- Lars Trolle
- Ulrich Krasilnikoff
Curasight A/S
Curasight is active in the pharmaceutical industry. The company specializes in research and development of various drug candidates. The product portfolio includes, for example, research and development within Positron Emission Tomography (PET) and related ancillary services. The business is operating with the largest presence within Scandinavia. Curasight is headquartered in Copenhagen.
News
- Transaction with shares in Curasight A/S made by managerial employee
- Half-year report Q2 2025
- Curasight announces acceptance of clinical trial application (CTA) for phase 1 trial with uTREAT[®] in brain cancer patients
- Curasight A/S announces outcome of T03 warrant exercise
- Curasight A/S submits Clinical Trial Application for Phase 1 trial with uTREAT[®] in brain cancer patients
News agencies
- MarketWire: Dansk biotekselskab runder begivenhedsrigt halvår af: EMA-godkendelse kronen på værket
- Finwire: Curasight rapporterar ökad rörelseförlust
- Finwire: Curasight rapporterar marginellt utnyttjande av teckningsoptioner
- Finwire: Curasight har lämnat in ansökan till EMA om fas 1-studie
- Finwire: Curasight genomför riktad emission till garanter - utspädning på 2,1 procent
Analysis
- SEB Research: Curasight: Good progress on uTRACE ph2, uTREAT ph1 - SEB
- Redeye: Curasight: 47% subscription in the rights issue - Redeye
- Redeye: Curasight Q1: Securing runway to readouts - Redeye
- SEB Research: Curasight: Rights issue brings new investors, including partner Curium - SEB
- Redeye: Curasight: DKK100m rights issue announced - Redeye
Videos
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Curium International Trading B.V | 19,60 | 19,60 | 2025-08-04 |
| Andreas Kjær | 15,96 | 15,96 | 2025-08-04 |
| UK Curacap ApS | 11,62 | 11,62 | 2025-08-04 |
| Carsten Haagen Nielsen | 5,25 | 5,25 | 2025-08-04 |
| Pentwater Capital Management LP | 5,18 | 5,18 | 2025-08-04 |
| Nordnet Bank AB | 2,06 | 2,06 | 2025-08-04 |
| Jacob Madsen | 2,04 | 2,04 | 2025-08-04 |
| Avanza Bank AB | 1,58 | 1,58 | 2025-08-04 |
| Chr. Olesen Holding A/S | 1,54 | 1,54 | 2025-08-04 |
| Lars Trolle | 1,29 | 1,29 | 2025-09-01 |
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)
Insider trading
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority
Key Numbers
*Compiled data from Millistream
Upcoming reports
-
2025-11-27 Delårsrapport 2025-Q3
Annual reports, prospectus etc.
- 2025-04-30 Information document 2025
- 2025-04-25 Annual Report 2024
- 2024-09-12 Prospekt 2024
- 2024-02-22 Memorandum 2024
- 2024-02-22 Curasight Annual Report 2023
- 2023-02-23 Annual Report 2022
- Show More
- 2022-02-24 Annual Report 2021
- 2021-02-24 Annual Report 2020
- 2020-09-07 Teaser 2020 SV
- 2020-09-03 Teaser ENG 2020
- 2020-09-02 Prospectus
- Close